Formulation and Evaluation of Controlled release of Losartan potassium matrix tablets using poly (Ethyleneoxides)

Order of Publishing in Issue: 
Volume :3
Issue :4
October, 2009 - December, 2009
Page No: 
R. L. C. Sasidhar [1] *, S. Vidyadhara [1] , J. Ramesh Babu [1] , R. Nagaraju [2] and K. Prakash Reddy [3]
[1] Chebrolu Hanumaiah Institute of Pharmaceutical Sciences , Chowdavaram, Guntur-6, Andhra Pradesh, India
[2] Institute of Pharmaceutical Technology, Sri Padmavathi Women’s University, Tirupathi, India
[3] Dr. Reddy’s laboratories, Hyderabad, India

Abstract : In the present investigation an attempt has been made to increase therapeutic efficacy, reduced frequency of administration and improved patient compliance by developing controlled release matrix tablets of Losartan Potassium. Losartan Potassium was formulated as oral controlled release matrix tablets by using poly(ethylene oxides) { Polyox WSR 303 }.The aim of this study was to investigate the influence of polymer level and type if fillers namely lactose [soluble filler], microcrystalline cellulose and anhydrous dibasic calcium phosphate [insoluble fillers] on the release rate and mechanism of Losartan Potassium from matrix tablets prepared by direct compression process. Higher polymeric content in the matrix decreased the release rate of drug because of increased tortuosity and decreased porosity. At lower polymeric level the rate and extent of drug release was elevated. On the other hand, replacement of lactose with anhydrous dibasic calcium phosphate and microcrystalline cellulose have significantly retarded the release rate of Losartan Potassium.

Losartan Potassium, Matrix tablets, Poly (ethylene oxides).
Paper-12.PDF77.84 KB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



Upcoming 0 events

  • No upcoming events available

User login